Sjögren’s disease (SjD) is an autoimmune disorder characterized by progressive salivary and lacrimal gland dysfunction, inflammation, and destruction, as well as extraglandular manifestations. SjD is associated with autoreactive B and T cells, but its pathophysiology remains incompletely understood. Abnormalities in regulatory T (T reg ) cells occur in several autoimmune diseases, but their role in SjD is ambiguous. We had previously shown that the function and development of T reg cells depend on store-operated Ca 2+ entry (SOCE), which is mediated by ORAI1 Ca 2+ channels and stromal interaction protein 1 (STIM1) and STIM2. Here, we show that mice with a Foxp3 + T reg cell–specific deletion of Stim1 and Stim2 develop a phenotype that fulfills all classification criteria of human SjD. Mutant mice have salivary and lacrimal gland inflammation characterized by strong lymphocyte infiltration and transcriptional signatures dominated by T helper 1 (T H 1) and interferon (IFN) signaling. CD4 + T cells from mutant mice are sufficient to induce SjD-like disease in an IFN-γ–dependent manner. Inhibition of IFN signaling with the JAK1/2 inhibitor baricitinib alleviated CD4 + T cell–induced SjD in mice. These findings are consistent with the transcriptional profiles of CD4 + T cells from patients with SjD, which indicate enhanced T H 1 but reduced memory T reg cell function. Together, our study provides evidence for a critical role of dysfunctional T reg cells and IFN-γ–producing T H 1 cells in the pathogenesis of SjD.
Oral cancer causes pain associated with cancer progression. We report here that the function of the Ca 2+ channel ORAI1 is an important regulator of oral cancer pain. ORAI1 was highly expressed in tumor samples from patients with oral cancer, and ORAI1 activation caused sustained Ca 2+ influx in human oral cancer cells. RNA-seq analysis showed that ORAI1 regulated many genes encoding oral cancer markers such as metalloproteases (MMPs) and pain modulators. Compared with control cells, oral cancer cells lacking ORAI1 formed smaller tumors that elicited decreased allodynia when inoculated into mouse paws. Exposure of trigeminal ganglia neurons to MMP1 evoked an increase in action potentials. These data demonstrate an important role of ORAI1 in oral cancer progression and pain, potentially by controlling MMP1 abundance.